BioIntelligence Technologies: Why We Invested
To catalyze industrial decarbonization, we must move away from energy-intensive manufacturing to more energy-efficient, low carbon footprint alternatives, such as bio-fermentation. Quebec-based BioIntelligence Technologies (BIT) provides solutions for reducing the carbon footprint in large-scale bio-manufacturing industries like chemical production, pharmaceuticals, cosmetics, and certain food applications. BIT's analytics can alleviate challenges in biomanufacturing by reducing production losses and increasing yields by 5-10% per batch. This improvement fosters the adoption of more sustainable manufacturing processes.
Redefining Returns: The Evolution of Venture Capital Into Impact Investing
Venture capitalists have traditionally focused on high returns and calculated risks. However, in today’s evolving market landscape, there’s a significant shift towards a more purpose-driven approach. Relying solely on financial gains is no longer sufficient. The demand from consumers, governments, and communities for investments that also yield environmental and social returns is growing. This is particularly crucial given the current state of our planet and the challenges faced by health and education systems. Impact investing emerges as a paradigm shift, redefining the fundamental principles of investment for double bottom-line returns.
Femtech Canada Officially Launches Network to Support Women’s Health Innovation
Kathryn Wortsman, managing partner at Amplify Capital, told BetaKit that she and Ella Seitz, a partner at Esplanade Ventures, also saw a gap in awareness of healthcare technology focused on women’s health when collaborating on deals in early 2023.
“As women ourselves, and in our respective positions as investment decision makers at our funds, we wanted to help amplify the startups in the space and lead the conversation on the financial and health impact opportunity that can come from investing in this segment,” Wortsman said.
Good investment: The ambitious fund that shows how social impact can pay dividends
Joining Amplify Capital was a life-changing decision for me, and I'm often asked why I made the move. The answer is simple: purpose and passion.
Amplify's mission to make a positive impact on climate, education, and healthcare struck a deep chord within me. I believe that business can be a powerful force for good, and I am thrilled to collaborate with mission-driven founders to create meaningful change in the world.
Welcome Louis Delorme to the Amplify Capital team!
Joining Amplify Capital was a life-changing decision for me, and I'm often asked why I made the move. The answer is simple: purpose and passion.
Amplify's mission to make a positive impact on climate, education, and healthcare struck a deep chord within me. I believe that business can be a powerful force for good, and I am thrilled to collaborate with mission-driven founders to create meaningful change in the world.
Carbon Upcycling raises $26M Series A led by BDC Capital and Climate Investment
Carbon Upcycling Technologies, a leader in circular decarbonization solutions for hard-to-abate sectors, including cement, steel, and mining, has closed a US$26 million Series A funding round co-led by BDC Capital’s Climate Tech Fund and Climate Investment.
The syndicate includes strong participation from existing financial investors, Clean Energy Ventures, its angel investor collective CEVG, Amplify Capital, and strategic investors, Oxy Low Carbon Ventures, CRH Ventures, and Cemex Ventures, which are all enhancing their financial support with commitments to strategically-relevant projects.
Ditch Labs secures $3.25 million to treat nicotine addiction with tech
Montréal-based healthtech startup Ditch Labs wants to help smokers wean themselves off nicotine with its dual hardware-software solution.
HMH Acquires Canadian EdTech Company Classcraft
PRNewswire/ -- Learning technology company HMH today announced the acquisition of Quebec-based education technology company, Classcraft.
American biotech Recursion acquires AI drug-discovery companies, Cyclica and Valence
An American biotech company is acquiring two Canadian startups in the artificial intelligence (AI) drug discovery space: Cyclica and Valence Discovery.
Future Fields: Why We Invested
Future Fields optimizes the biomanufacturing process, enabling more opportunities for cost-effective alternative proteins. As a result, Future Fields will support the decarbonization industries while offering a scalable solution to meet food, pharmaceutical, and other urgent and necessary needs globally.